Practice Question Answers: AIDS-Related Noninfectious Dermatoses

1. What is considered to be the most common skin finding in human immunodeficiency virus/AIDS patients?

a. atopic dermatitis

b. atypical nevi

c. basal cell carcinoma

d. psoriasis

e. seborrheic dermatitis

2. You are treating a patient with widespread psoriasis who also has human immunodeficiency virus and is currently on highly active antiretroviral therapy. What would not be the best option for treatment?

a. acitretin

b. adalimumab

c. cyclosporine

d. infliximab

e. topical steroids

 

3. Which of the following conditions is seen in human immunodeficiency virus patients and is associated with the human papillomavirus?

a. basal cell carcinoma

b. cervical intraepithelial neoplasia

c. eosinophilic folliculitis

d. Kaposi sarcoma

e. squamous cell carcinoma

4. Which of the following cosmetic products is US Food and Drug Administration approved for treatment of AIDS-associated lipodystrophy?

a. abobotulinumtoxin

b. calcium hydroxylapatite

c. hyaluronic acid

d. incobotulinumtoxin

e. silicone

5. Which of the following dermatologic conditions typically does not present until the CD4 count is less than 200 cells/mm³?

a. atopic dermatitis

b. basal cell carcinoma

c. Kaposi sarcoma

d. pruritic papular eruption

e. psoriasis

1. What is considered to be the most common skin finding in human immunodeficiency virus/AIDS patients?

a. atopic dermatitis

b. atypical nevi

c. basal cell carcinoma

d. psoriasis

e. seborrheic dermatitis

2. You are treating a patient with widespread psoriasis who also has human immunodeficiency virus and is currently on highly active antiretroviral therapy. What would not be the best option for treatment?

a. acitretin

b. adalimumab

c. cyclosporine

d. infliximab

e. topical steroids

 

3. Which of the following conditions is seen in human immunodeficiency virus patients and is associated with the human papillomavirus?

a. basal cell carcinoma

b. cervical intraepithelial neoplasia

c. eosinophilic folliculitis

d. Kaposi sarcoma

e. squamous cell carcinoma

4. Which of the following cosmetic products is US Food and Drug Administration approved for treatment of AIDS-associated lipodystrophy?

a. abobotulinumtoxin

b. calcium hydroxylapatite

c. hyaluronic acid

d. incobotulinumtoxin

e. silicone

5. Which of the following dermatologic conditions typically does not present until the CD4 count is less than 200 cells/mm³?

a. atopic dermatitis

b. basal cell carcinoma

c. Kaposi sarcoma

d. pruritic papular eruption

e. psoriasis

1. What is considered to be the most common skin finding in human immunodeficiency virus/AIDS patients?

a. atopic dermatitis

b. atypical nevi

c. basal cell carcinoma

d. psoriasis

e. seborrheic dermatitis

2. You are treating a patient with widespread psoriasis who also has human immunodeficiency virus and is currently on highly active antiretroviral therapy. What would not be the best option for treatment?

a. acitretin

b. adalimumab

c. cyclosporine

d. infliximab

e. topical steroids

 

3. Which of the following conditions is seen in human immunodeficiency virus patients and is associated with the human papillomavirus?

a. basal cell carcinoma

b. cervical intraepithelial neoplasia

c. eosinophilic folliculitis

d. Kaposi sarcoma

e. squamous cell carcinoma

4. Which of the following cosmetic products is US Food and Drug Administration approved for treatment of AIDS-associated lipodystrophy?

a. abobotulinumtoxin

b. calcium hydroxylapatite

c. hyaluronic acid

d. incobotulinumtoxin

e. silicone

5. Which of the following dermatologic conditions typically does not present until the CD4 count is less than 200 cells/mm³?

a. atopic dermatitis

b. basal cell carcinoma

c. Kaposi sarcoma

d. pruritic papular eruption

e. psoriasis